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Sebum Free Fatty Acids Enhance the Innate Immune
Defense of Human Sebocytes by Upregulating
b-Defensin-2 Expression
Teruaki Nakatsuji1,2, Mandy C. Kao1,2, Liangfang Zhang3,4, Christos C. Zouboulis5, Richard L. Gallo1,2 and
Chun-Ming Huang1,2,4
Various sebum free fatty acids (FFAs) have shown antibacterial activity against a broad range of Gram-positive
bacteria, resulting in the suggestion that they are accountable, at least partially, for the direct antimicrobial
activity of the skin surface. In this study, we examined the effects of sebum FFAs on the antimicrobial peptide
(AMP)-mediated innate immune defense of human sebocytes. Incubation of lauric acid, palmitic acid, or oleic
acid (OA) with human sebocytes dramatically enhanced their expression of human b-defensin (hBD)-2, one of
the predominant AMPs found in the skin, whereas remarkable increases in hBD-1, hBD-3, and human
cathelicidin LL-37 were not observed. Secreted hBD-2 was detectable by western blotting in the supernatant of
sebocyte culture incubated with each FFA, but not with a vehicle control. The supernatant of FFA-incubated
sebocyte culture showed antimicrobial activity against Propionibacterium acnes, whereas the enhanced
antimicrobial activity of human sebocytes was neutralized by anti-hBD-2 IgG. In addition, the FFA-induced
hBD-2 expression was suppressed by blocking the cluster of differentiation (CD)36 fatty acid translocase on
the surface of sebocytes with anti-human CD36 IgG or blocking the NF-kB signaling pathway with BMS-345541,
a highly selective inhibitor of inhibitory kB kinase. These data suggest that sebum FFAs upregulate the expression
of hBD-2 in human sebocytes, which may enhance the disinfecting activity of the human sebaceous gland.
The FFA-induced upregulation of hBD-2 is facilitated by CD36-mediated FFA uptake and NF-kB-mediated
transactivation. The upregulation of mouse b-defensin 4, a mouse ortholog for hBD-2, was also observed in
the hair follicle sebaceous glands of mouse ear skin after an epicutaneous application of OA, the most hBD-2-
inducible FFA tested. This report highlights the potential of using FFAs as a multifunctional antimicrobial
therapy agent for acne vulgaris treatment; FFAs may provide direct antibacterial activities against P. acnes and
enhance the skin’s innate antibacterial defense by inducing the expression of hBD-2 in sebocytes as well.
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INTRODUCTION
Propionibacterium acnes is a Gram-positive anaerobic
bacterium residing in pilosebaceous follicles as a member
of the resident bacterial flora in the human skin. Once it
overgrows and colonizes in sebaceous hair follicles, P. acnes
is pertinent to the development of inflammatory acne
vulgaris, which is the most common skin disease, afflicting
up to 80% of individuals throughout their lives (Nordstrom
et al., 1986; Chronnell et al., 2001; Bojar and Holland,
2004). The inflammation of severe acne is initiated by
disruption of the follicular epithelium due to the overgrowth
of P. acnes, followed by the spread of the bacteria from the
microcomedone to the dermis, in which they interact with
various skin and immune cells such as keratinocytes and
macrophages, triggering granulomatous reactions of inflam-
matory acne (Marples et al., 1971; Toyoda and Morohashi,
2001; Degitz et al., 2007). The bacteria stimulate the
production of proinflammatory cytokines, including inter-
leukins-1b, -8, and -12, and tumor necrosis factor-a. It is
known that P. acnes-induced cytokine production is
mediated by Toll-like receptor 2 (Kim et al., 2002; Kim,
2005; Nagy et al., 2006).
The skin epithelium participates in self-disinfection of the
human skin surface through various modes of action. It has
& 2010 The Society for Investigative Dermatology www.jidonline.org 985
ORIGINAL ARTICLE
Received 8 April 2009; revised 21 September 2009; accepted 15 October
2009; published online 24 December 2009
1Division of Dermatology, Department of Medicine, University of California,
San Diego, San Diego, California, USA; 2VA San Diego Healthcare Center,
San Diego, California, USA; 3Department of Nanoengineering, University of
California, San Diego, San Diego, California, USA; 4Moores Cancer Center,
University of California, San Diego, San Diego, California, USA and
5Department of Dermatology, Venereology, Allergology and Immunology,
Dessau Medical Center, Dessau, Germany
Correspondence: Chun-Ming Huang, Division of Dermatology, Department
of Medicine, University of California, San Diego, Room 2317A, 3350 La Jolla
Village, San Diego, California 92161, USA. E-mail: chunming@ucsd.edu
Abbreviations: AMP, antimicrobial peptide; CD, cluster of differentiation;
CFU, colony-forming unit; FBS, fetal bovine serum; FFA, free fatty acid;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; hBD, human b-
defensin; IKK, inhibitory kB kinase; LA, lauric acid; mBD-4, mouse b-
defensin-4; OA, oleic acid; PA, palmitic acid; PBS, phosphate-buffered saline
been widely accepted that antimicrobial peptides (AMPs)
are major contributors to cutaneous innate nonspecific
immunity, which is the first line of defense against invading
pathogens (Nizet et al., 2001; Zasloff, 2002). Cathelicidins
and b-defensins are the best-characterized AMPs found
in the skin. Human b-defensin (hBD)-1 is constitutively
expressed in keratinocytes, whereas hBD-2, hBD-3, and
human cathelicidin LL-37 are typically upregulated in
keratinocytes during inflammation and then accumulate in
the skin (Gallo et al., 2002; Froy, 2005). Because of their
direct antimicrobial action, the secretion of these peptides
provides a defense against infectious pathogens. Recent
evidence has indicated that human sebaceous glands may
contribute to the skin immune defense by releasing AMPs.
For example, hBDs are expressed in human pilosebaceous
units and their expression is upregulated in acne lesions
(Chronnell et al., 2001). Cathelicidin and hBD-2 are detected
in cultured human sebocytes, the predominant cells residing
in the sebaceous gland, and their expression levels are
upregulated in the presence of P. acnes (Nagy et al., 2006;
Lee et al., 2008). Free fatty acids (FFAs) are ubiquitously
found on the surface of the human skin and are the
predominant components in human sebum. FFAs are
produced via hydrolysis of their precursors, sebum triacyl-
glycerides secreted from sebaceous glands, by lipases that are
secreted from commensal bacterial flora such as P. acnes and
Staphylococcus epidermidis (Marples et al., 1971; Holland
et al., 1981; Gotz et al., 1998); they can also be produced by
sebocytes in the absence of bacteria (Fujie et al., 1996;
Zouboulis et al., 1999). Because various FFAs have shown
antibacterial activity against a broad range of Gram-positive
bacteria in vitro, FFAs, together with AMPs, have been
considered to be responsible for at least a part of the innate
immune defense of the skin surface against microbial
colonization and infection (Drake et al., 2008). Therefore,
sebaceous glands may have a very significant role in skin
self-disinfection by both providing antimicrobial agents to the
external skin surface and contributing to the cutaneous innate
immune defense.
Recently, we demonstrated that lauric acid (LA) (C12:0),
one of the sebum FFAs (Bodoprost and Rosemeyer, 2007),
has strong antimicrobial activity in vitro against skin bacteria,
including P. acnes. Topical application or intradermal
injection of LA in vivo shows remarkable therapeutic
effectiveness against P. acnes-induced inflammation
and significant reduction in the number of bacteria (Nakatsuji
et al., 2009). In this study, we examined the effects of
sebum FFAs on the AMP-mediated cutaneous innate immune
defense of human sebocytes and mouse skin. We found
that LA, palmitic acid (PA; 16:0), and oleic acid (OA; C18:1,
cis-9), which are the typical FFAs found in human
sebum, enhanced the hBD-2 expression and antimicrobial
activity of human sebocytes against P. acnes. Our data
suggest that sebum FFAs are involved in the disinfecting
activity of the human skin both through their
direct antimicrobial characteristics and by inducing AMPs
in human sebocytes to enhance their innate immune defense
ability.
RESULTS
FFA-induced increase of AMP expression in human sebocytes
To examine the effects of sebum-containing FFAs on the
expression of the predominant AMPs in the human skin, such
as hBD-1, -2, and -3 and human cathelicidin LL-37, human
SZ95 sebocytes were incubated with LA, PA, or OA for 24hours.
After incubation, we first demonstrated that FFAs had a
negligible effect on the cell viability of human SZ95 sebocytes
(see Supplementary Figure S1 online). We further found that
FFAs did not enhance hBD-1 expression in comparison with
vehicle control (Figure 1a). In contrast, hBD-2 expression
was remarkably enhanced by incubation with LA (54-fold),
PA (25,170-fold), or OA (45,260-fold) (Figure 1b). hBD-3
expression was significantly enhanced by PA (382-fold), but
not by LA or OA (Figure 1c). Cathelicidin expression was
slightly enhanced by PA (3.3-fold) and OA (3.3-fold), but not
by LA. Overall, the hBD-2 expression level was upregulated
most when human sebocytes were incubated with the FFAs.
An increase in the amount of hBD-2 peptide in SZ95
sebocytes after incubation with FFAs was further confirmed by
immunofluorescent staining with anti-hBD-2 IgG (Figure 2a). In
addition, an increase in hBD-2 secreted into the culture
medium was confirmed by western blotting. A single band
was detected at the expected size (5 kDa) after incubation with
each FFA, whereas no bands were detected in the vehicle
control, indicating that the basal secretion level of hBD-2 from
the cell line is very low (Figure 2b). These data suggest the AMP
inducibility of LA, PA, and OA in human sebocytes.
Neutralization of FFA-induced antimicrobial activity of human
sebocytes with anti-hBD-2 IgG
We first incubated human SZ95 sebocytes with LA, PA, or
OA at 25 mgml1 for 24 hours to enhance their AMP
expression. Separate experiments were conducted by incu-
bating FFAs at various concentrations (0–100mgml1) with
P. acnes to confirm that FFAs alone at 25 mgml1 do not exert
antimicrobial activity against P. acnes (see Supplementary
Figure S2). To examine the antimicrobial activity of FFA itself
contained in the medium, the FFA-conditioned medium was
incubated without sebocytes. Next, we tried to neutralize the
hBD-2-mediated antimicrobial activity of the FFA-treated
human sebocytes. To this end, the supernatant of the culture
medium of the FFA-treated sebocytes or the FFA-conditioned
medium was preincubated with anti-hBD-2 IgG for 2 hours to
produce a mixture solution; normal IgG was used as control.
The antimicrobial activity of the mixture solution was then
evaluated against P. acnes using a solution killing assay. The
bacteria were incubated in the mixture solution for 5 hours at
37 1C and then diluted with PBS and spotted on an agar plate
for the counting of colony-forming units (CFUs). As shown in
Figure 3, the supernatant that was preincubated with normal
IgG significantly reduced the number of P. acnes bacteria as
compared with the corresponding control medium contain-
ing FFAs (Figure 3). However, the supernatant preincubated
with anti-hBD-2 IgG neutralized the antimicrobial activity of
the supernatant (Figure 3). These data suggest that hBD-2 is
involved in the FFA-enhanced antimicrobial activity of
human sebocytes.
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Antimicrobial activity of hBD-2 on P. acnes
To examine the antimicrobial activity of the hBD-2 peptide
on P. acnes, bacteria were incubated with several concentra-
tions of synthetic hBD-2 for 5 hours at 37 1C. After incuba-
tion, the bacteria were diluted with PBS and spotted on an
agar plate so that CFUs could be counted (Figure 4a).
Strikingly, at concentrations higher than 10 mM, hBD-2 killed
P. acnes. In contrast, no killing was observed when the hBD-
2 concentration was 2.5 mM. Given that hBD-2 may be
released from sebocytes along with FFAs in the human skin,
the next experiment was conducted to examine synergistic
antimicrobial activity of hBD-2 and FFAs. P. acnes was
incubated with synthetic hBD-2 in combination with
25 mgml1 of LA, PA, or OA, a concentration at which each
FFA alone does not exert antimicrobial activity (see Supple-
mentary Figure S2). hBD-2 (2.5 and 5mM) synergistically
killed P. acnes in combination with LA, but not with PA or
OA (Figure 4b), suggesting synergistic antimicrobial activity
of hBD-2 and LA.
Detection of CD36 in human sebocytes by
immunocytochemical analysis
After discovering that FFAs enhance the antimicrobial activity
of human sebocytes, we examined the mechanism of FFA
translocation into sebocytes. Because the cluster of differ-
entiation (CD)36 is known to be a key protein involved in
regulating the uptake of FFAs across the plasma membrane in
various tissues, we assessed the presence of CD36 in human
SZ95 sebocytes using an immunocytochemical method.
Using anti-CD36 IgG as the primary antibody, we found that
immunoreactivity (green fluorescence) was widely revealed
in the sebocytes, but when we used normal mouse IgG, no
immunoreactivity was detected in the cells (Figure 5a).
Moreover, CD36 immunoreactivity was located predomi-
nantly at the peripheral margins of cells, indicating that CD36
is a membrane-associated protein in human sebocytes.
Involvement of CD36 and NF-jB signaling in FFA-enhanced
hBD-2 expression
Subsequent experiments were designed to explore the
connection between CD36-mediated uptake of FFAs and
FFA-induced increase of hBD-2 expression. Human sebo-
cytes were preincubated with anti-CD36 IgG or normal IgG
for 2 hours. After the preincubation, LA, PA, or OA was added
to the cell culture medium and subsequently incubated for
24 hours. Neither preincubation with anti-CD36 IgG nor
subsequent incubation with each FFA affected the viability
of sebocytes (see Supplementary Figure S3a). As shown in
Figure 5, for cells preincubated with normal control IgG, the
addition of LA, PA, or OA enhanced the hBD-2 expression
by 561-, 2,763-, or 35,627-fold, respectively, in comparison
with the vehicle control (Figure 5b). However, for cells
preincubated with anti-CD36 IgG, the addition of LA, PA, or
OA showed a marginal enhancement of hBD-2 expression,
by 16-, 19-, or 361-fold, respectively. These data suggest that
the FFA-induced increase of hBD-2 expression in human
sebocytes is mediated by CD36 on the cell surface.
Given that hBD-2 expression is facilitated by the NF-kB-
mediated transactivation pathway in many cell types, we next
examined the connection between the FFA-induced increase
of hBD-2 expression and the NF-kB signal pathway in human
SZ95 sebocytes. To block NF-kB-mediated signaling in
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Figure 1. Effect of FFAs on the antimicrobial peptide expression in human sebocytes. Immortalized human sebocytes, SZ95 (1 106 per well), were incubated
with LA, PA, or OA (25 mgml1) in 1% FBS-Sebomed containing 0.5% (w/v) DMSO for 24 hours at 37 1C. The control received an equal amount of DMSO.
(a–d) mRNA expression of hBD-1 (a), hBD-2 (b), hBD-3 (c), and human cathelicidin LL-37 (d) was evaluated by real-time qPCR, normalized to that of GAPDH,
and then plotted as relative expression compared with that of vehicle-treated cells. Data represent means±SE of four individual experiments (*Po0.05,
**P o0.01, ***Po0.005 by Student’s t-test vs. vehicle control). FBS, fetal bovine serum; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; hBD, human b-defensin; LA, lauric acid; OA, oleic acid; PA, palmitic acid; qPCR, quantitative PCR.
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sebocytes, cells were preincubated with BMS-345541, a
highly selective inhibitor of inhibitory kB kinase (IKK), or with
an equal amount of DMSO for 1 hour at 37 1C. The cells were
then incubated with LA, PA, OA, or an equal amount of
DMSO for 24 hours at 37 1C (Figure 5c). It was found that
preincubation with BMS-345541 completely suppressed the
FFA-induced increase of hBD-2 expression in human
sebocytes. Neither treatment affected the viability of sebo-
cytes (see Supplementary Figure S3b).
Effect of epicutaneous application of OA on mBD-4 expression
in mouse skin
Because OA is the most hBD-2-inducible FFA tested
(Figure 1), we examined its effect on the expression of mouse
b-defensin-4 (mBD-4), a mouse ortholog for hBD-2 (Jia et al.,
2000), in the skin of mouse ears. Immunoreactivity of mBD-4
in the hair follicle sebaceous glands of mouse ear skin was
enhanced after epicutaneous application of OA, whereas
little reaction was observed after vehicle treatment
(Figure 6a). No immunoreactivity was found with a normal
rabbit IgG used as a negative control. In addition, treatment
with OA dramatically enhanced mBD-4 gene expression in
mouse ear skin by 198-fold in comparison with the vehicle
treatment (Figure 6b). As shown in Supplementary Figure S4,
hBD-2 expression in keratinocytes was slightly enhanced by
incubation with LA, PA, or OA, suggesting that sebocytes,
and not keratinocytes, primarily contribute to the FFA-induced
enhancement of defensin expression in the skin. All data
were comparable to in vitro data using the human sebocyte
cell line.
DISCUSSION
Most microorganisms residing in the human skin, such as
P. acnes and S. epidermidis, possess lipolytic activity, which
is believed to be responsible for the hydrolysis of sebaceous
lipids, liberating FFAs to the skin surface (Marples et al.,
1971; Holland et al., 1981; Gotz et al., 1998), although
genuine FFA production by human sebocytes is also possible
(Fujie et al., 1996; Zouboulis et al., 1999). Because some
middle- to long-chain FFAs (C8-C18) have shown antibacter-
ial activity against a broad range of Gram-positive bacteria
(Wille and Kydonieus, 2003; Georgel et al., 2005; Skrivanova
et al., 2005; Drake et al., 2008), they are considered to be
responsible for at least a part of the direct antimicrobial
activity of the skin surface against pathogen colonization and
infection. LA is a minor sebum component, but it is the most
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Figure 2. FFA-enhanced hBD-2 peptide level in human sebocytes. (a) Immortalized human sebocytes, SZ95 (2 106 per well), were incubated with LA, PA, or
OA (25mgml1) in 1% FBS-Sebomed containing 0.5% (w/v) DMSO for 24 hours at 37 1C. The control received an equal amount of DMSO. After incubation, the
cells were stained with rabbit anti-hBD-2, followed by FITC-labeled anti-rabbit IgGs. The nuclei were counterstained with DAPI. Bar¼10 mm. (b) To detect
secreted hBD-2 from SZ95 sebocytes by western blotting, the supernatants of the cell culture media were concentrated using a Sep-Pak cartridge as described
in the Materials and Methods section. The reconstituted samples (400 ml equivalent of medium) from cell culture media, incubated with vehicle, LA, PA,
and OA (lanes 2–5, respectively), were separated by SDS-PAGE (16% acrylamide). Synthetic hBD-2 (60 nmol) was used as a positive control (lane 1) for
detection of hBD-2. hBD-2 was detected by rabbit anti-hBD-2 IgGs. Data are representative of three separate experiments with similar results. Lane 1 and lanes
2–5 are from the same original gel. Because of different film exposure times, two images were obtained and later merged again. DAPI, 40-6-diamidino-2-
phenylindole; FBS, fetal bovine serum; FFA, free fatty acid; hBD-2, human b-defensin-2; LA, lauric acid; OA, oleic acid; PA, palmitic acid.
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active antimicrobial FFA (Kabara et al., 1972; Kitahara et al.,
2004; Rouse et al., 2005; Skrivanova et al., 2005). Our
previous study has confirmed the potent antimicrobial
activity of LA against P. acnes in vitro and the therapeutic
potential against P. acnes-induced inflammation in vivo
(Nakatsuji et al., 2009). Conversely, PA and OA, the most
predominant FFAs found in human sebum (Bodoprost and
Rosemeyer, 2007), did not exert potent bactericidal activity
against P. acnes in vitro (data not shown). In the present
study, we demonstrated that LA, PA, and OA dramatically
enhanced the hBD-2 expression level in human sebocytes
(Figures 1b and 2a) and the secretion of hBD-2 into the
medium (Figure 2b). The supernatant of the sebocyte culture
medium containing LA, PA, or OA showed significant
antimicrobial activity against P. acnes when the supernatant
was incubated with normal control IgG. However, the
observed antimicrobial activity was neutralized when the
supernatant was incubated with anti-hBD-2 IgG before its
antimicrobial activity against P. acnes was evaluated
(Figure 3). These results suggest that the FFA-induced
antimicrobial activity of sebocytes is at least mediated by
hBD-2. Consistent with our observation, Chronnell et al.
(2001) found that hBD-2 expression was upregulated in acne
lesions. Because increased quantities of FFAs have been
observed in the skin of acne patients (Ito et al., 1996), the
increase in hBD-2 expression in acne lesions might be
associated with sebum FFAs. However, Nagy et al. (2005)
reported that recombinant hBD-2, in concentrations of up to
2.5 mgml1 (0.5 mM), exerted no antimicrobial effect on the
viability of any strains of P. acnes tested. We observed that
synthetic hBD-2 peptide (5–20 mM) dose-dependently killed
P. acnes in vitro at these higher concentrations (Figure 4a).
The combination of hBD-2 and human cathelicidin LL-37,
both of which are also produced in human sebocytes (Nagy
et al., 2006; Lee et al., 2008), has shown synergistic
antimicrobial activity against group B Streptococcus in vitro
(Dorschner et al., 2003). Our group has recently demon-
strated that histone H4 is an important functional AMP
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Figure 3. Neutralization of FFA-induced antimicrobial activity of human
sebocytes with anti-hBD-2 IgG. Immortalized human sebocytes, SZ95
(2106 per well), were incubated with LA, PA, or OA (25 mgml1) in 1%
FBS-Sebomed containing 0.5% (w/v) DMSO for 24 hours at 37 1C. An equal
amount of DMSO was used as vehicle control. To examine the antimicrobial
activity of each FFA contained in the medium, the FFA-conditioned medium
was incubated without sebocytes. After incubation, the supernatant of the cell
culture was filtrated to remove cell debris and then preincubated with rabbit
anti-hBD-2 IgG or normal rabbit IgG for 2 hours at 37 1C. The mixture was
incubated with Propionibacterium acnes (1 106CFU per ml) for 5 hours at
37 1C under anaerobic conditions. After incubation, the P. acnes suspension
was diluted 1:1-1:104 with PBS. A volume of 5 ml of the diluted solution was
spotted on a Brucella broth agar plate supplemented with 5% defibrinated
sheep blood and hemin and with vitamin K. After the liquid in the P. acnes
suspension was absorbed into the agar, the plate was incubated under
anaerobic conditions to quantify the CFUs of P. acnes. Data represent
means±SE of three individual experiments (*Po0.05, **P o0.01 by
Student’s t-test vs. medium control). CFU, colony-forming unit; FBS, fetal
bovine serum; FFA, free fatty acid; hBD-2, human b-defensin-2; LA, lauric
acid; OA, oleic acid; PA, palmitic acid; PBS, phosphate-buffered saline.
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Figure 4. Bactericidal effect of synthetic hBD-2 on Propionibacterium acnes.
(a) P. acnes (1106CFU per ml) was incubated with 0–20mM synthetic hBD-2
peptide in 20mM phosphate buffer, pH 6.5, containing 100mM NaCl for 5 hours
under anaerobic conditions. (b) To enable examination of the synergistic
antimicrobial activity of hBD-2 and FFAs, P. acnes (1 106 CFU per ml) was
incubated with hBD-2 (0, 2.5, 5, 10mM) in phosphate buffer in the presence
of LA, PA, or OA (25mgml1) on a 96-well microplate (100ml per well) at
37 1C for 5hours. The control received only DMSO (0.5% (v/v)) instead of FFA.
After incubation, the P. acnes suspension was diluted 1:10-1:104 with PBS,
and 5ml of the diluted solution was spotted on a Brucella broth agar plate
supplemented with 5% defibrinated sheep blood and hemin and with vitamin K.
After the liquid in the P. acnes suspension was absorbed into the agar,
the plate was incubated under anaerobic conditions to quantify the CFUs
of P. acnes. Data represent means±SE of three individual experiments
(*Po0.05, ***Po0.005 by Student’s t-test). CFU, colony-forming unit;
FFA, free fatty acid; hBD-2, human b-defensin-2; LA, lauric acid; OA, oleic acid;
PA, palmitic acid; PBS, phosphate-buffered saline; UD, undetectable.
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released by human sebocytes and has a synergistic anti-
microbial effect with LA or OA at sublethal doses against
Staphylococcus aureus (Lee et al., 2009). In this study, the
combination of hBD-2 and LA at sublethal doses exerted
synergistic antimicrobial activity against P. acnes (Figure 4b).
These findings suggest that in the human pilosebaceous
microenvironment, antimicrobial components secreted from
sebocytes can synergistically enhance their antimicrobial
activity, thereby providing potent skin antimicrobial defense
against pathogen colonization and infection.
Several pathways allow the uptake of FFAs into cells. As a
result of their hydrophobic nature and ability to transfer
passively across the phospholipid bilayer, translocation of
FFAs can occur in part simply by a diffusion mechanism
(Hamilton et al., 2001). In addition, several lines of evidence
suggest that FFA translocation involves a number of plasma
membrane-associated proteins such as the scavenger recep-
tor CD36, plasma membrane-bound fatty acid-binding
protein, and fatty acid transport protein (Abumrad et al.,
1999; Goldberg et al., 2008). CD36 has been well
characterized as a fatty acid translocase and is known to be
a key protein involved in regulating the uptake of FFAs across
the plasma membrane in various tissues such as the heart,
skeletal muscle, and adipose tissue (Goldberg et al., 2008).
Our data showed that CD36 exists on the surface of SZ95
sebocytes (Figure 5a). The CD36 protein has two transmem-
brane segments, very short intracellular segments, and a large
glycosylated extracellular domain that functions as a fatty
acid-binding domain (Baillie et al., 1996). Blocking CD36
with specific monoclonal IgG against its extracellular fatty
acid-binding domain partially suppressed the FFA-induced
increase in hBD-2 expression in human sebocytes (Figure 5b),
suggesting that the CD36-mediated translocation mechanism
of FFAs is involved in the FFA-induced increase of hBD-2
expression in human sebocytes. CD36 has higher selectivity
to longer-chain FFAs (Gaillard et al., 2008). This might
explain why PA and OA have a higher hBD-2 inducibility
than LA (Figure 1). In future experiments, it will be interesting
to investigate whether the production of FFAs or triacylgly-
cerides by sebocytes is influenced by treatment with FFAs.
The increase in the intracellular concentrations of FFAs
and their metabolites can activate signal transduction path-
ways in various tissues. For example, they can induce
inflammation and impair insulin signaling in the skeletal
muscle and liver (Boden et al., 2005; de Luca and Olefsky,
2008). Intracellular FFAs are converted into acyl-coenzyme
A’s by acyl-coenzyme A synthetases in the cytoplasm. Acyl-
coenzyme A’s in turn activate several serine/threonine
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Figure 5. FFA-induced increase of hBD-2 expression was mediated by CD36 and the NF-jB signaling pathway. (a) To reveal the cellular distribution of CD36 in
human SZ95 sebocytes, cells were stained with mouse anti-CD36 IgG, followed by anti-mouse IgG-FITC conjugate (green) (left panel). Normal mouse IgG was
used as negative control (right panel). The nuclei were counterstained with DAPI (blue). Data are representative of four separate experiments with similar results.
Bar¼50 mm. (b–c) To block the function of CD36 on the surface of SZ95 sebocytes, cells (2 106 per well) cultured on a 24-well plate were preincubated with
mouse anti-CD36 IgG (5 mgml1) or normal mouse IgG in 1% FBS-Sebomed (250 ml) for 2 hours at 37 1C (b). To block NF-kB-mediated signaling in SZ95
sebocytes, the cells (2106 per well) cultured on a 24-well plate were preincubated with BMS-345541 (20 mM) or with an equal amount of DMSO (0.1%) in 1%
FBS-Sebomed (250 ml) for 1 hour at 37 1C (c). After preincubation, LA, PA, or OA (25mgml1) was added to the cells, which were subsequently incubated for
24 hours at 37 1C. Control received an equal amount of DMSO (0.5% (v/v)). After incubation, the mRNA expression levels of hBD-2 were determined as
described in the Materials and Methods section. Data represent means±SE of four individual experiments (*Po0.05, **Po0.01, ***Po0.005 by Student’s t-test
vs. normal IgG or vehicle control). CD36, cluster of differentiation 36; DAPI, 40-6-diamidino-2-phenylindole; FBS, fetal bovine serum; FFA, free fatty acid;
hBD-2, human b-defensin-2; LA, lauric acid; OA, oleic acid; PA, palmitic acid.
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kinases, such as protein kinase C and IKKb (Delarue and
Magnan, 2007). IKKb is a member of the IKK complex, which
is a key enzyme involved in the phosphorylation of IkB, a
protein that suppresses the activation of NF-kB complexes,
resulting in its degradation by the proteasome (Ghosh and
Hayden, 2008). The released NF-kB complexes then translo-
cate into the nucleus and regulate the expression of target
genes involved in inflammatory reactions and initiation of
innate immune responses. Because hBD-2 expression is
facilitated by NF-kB-mediated transactivation in many cell
types (Froy, 2005), we subsequently examined the potential
connection between the FFA-induced increase of hBD-2
expression and NF-kB signal transduction in human
sebocytes. When sebocytes were preincubated with BMS-
345541, a highly selective inhibitor of IKK, the FFA-induced
increase of hBD-2 expression in human sebocytes was
completely suppressed (Figure 5c). This indicates that the
FFA-induced hBD-2 expression is mediated by the NF-kB
signaling pathway.
hBD-2 is expressed in a variety of tissues and is inducible
by bacterial and viral products (Froy, 2005). In addition,
hBD-2 is inducible by cytokines, such as tumor necrosis
factor-a and IL-1b (Harder et al., 1997; Wehkamp et al.,
2006), which are induced in keratinocytes by P. acnes. Thus,
hBD-2 is expected to have a critical role in the host defense
against pathogen infection as an inducible component
existing in the epithelial barrier. To our knowledge, this
study is the first to demonstrate that sebum FFAs upregulate
hBD-2 expression in human sebocytes, which may enhance
the disinfecting activity of the human sebaceous gland. Given
that extracellular lipases secreted by bacteria can hydrolyze
sebum triacylglycerides to produce FFAs, sebocytes may
become an important sensor of abnormal overgrowth of
pathogens such as P. acnes in pilosebaceous units, which
induces local inflammation such as inflammatory acne
vulgaris. Although LA is a potent antimicrobial FFA found
in human sebum, it shows less potency in inducing hBD-2
expression in human sebocytes than do other FFAs, such as
PA and OA. Conversely, PA and OA, the most predominant
FFAs found in human sebum, do not have a strong anti-
microbial activity against P. acnes (see Supplementary Figure
S2), although they show a higher hBD-2-inducible activity
than LA. These results suggest that LA may provide a direct
antimicrobial defense, whereas both PA and OA induce
antimicrobial defenses indirectly via the upregulation of
hBD-2 expression in human sebocytes. In addition to the
FFAs tested (Figure 1), other fatty acids may have the
capability of inducing AMPs. For example, ceramide, a
major lipid accounting for B50% of the lipid in the stratum
corneum (Downing et al., 1986), can trigger NF-kB activation
(Schutze et al., 1992; Higuchi et al., 1996), leading to the
induction of hBD-2 expression. Conversely, linoleic acid
(C18:2, cis,cis-9,12), a polyunsaturated FFA with anti-
inflammatory activity, can suppress NF-kB in human mono-
cytes (Zhao et al., 2005), suggesting that linoleic acid
attenuates the NF-kB-mediated host immune defense. Thus,
the roles of FFAs in the antimicrobial defense of sebocytes
may depend on the length of their carbon chain and degree of
saturation. Most importantly, the obtained data highlight the
potential of using FFAs as a multifunctional antimicrobial
therapy for acne vulgaris; FFA therapies may concurrently
provide direct antibacterial activity and enhance the skin’s
innate antibacterial defense by inducing AMPs in sebocytes.
We also observed the accumulation of mBD-4, a mouse
ortholog for hBD-2, in the hair follicle sebaceous glands and
upregulation of mBD-4 mRNA in the mouse ear skin after
epicutaneous application of OA (Figure 6). The data strongly
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Figure 6. Effect of epicutaneous application of OA on mBD-4 expression in
mouse sebaceous gland. OA (150mg in 5% acetone mixed with 15mg of
Vaseline) and 5% acetone mixed with 15mg of Vaseline (vehicle) were
epicutaneously applied to the left and right ears, respectively, at 0 and
12hours. The ears were excised 12 hours after epicutaneous application.
(a) Frozen sections of mouse ears were stained with rabbit anti-mBD-4 IgG,
followed by goat anti-rabbit IgG-Alexa 568 conjugate (red). Normal rabbit
IgG was used as negative control staining. Nuclei were stained with DAPI
(blue). Bar¼100 mm. Data are representative of four separate experiments
with similar results. (b) mRNA expression of mBD-4 in the ear skin was
evaluated by real-time qPCR, normalized to that of GAPDH, and then plotted
as relative expression compared with that of the vehicle-treated sample. Data
represent means±SE of four individual experiments (*Po0.05 by Student’s
t-test vs. vehicle-treated control). DAPI, 40-6-diamidino-2-phenylindole;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; mBD-4, mouse
b-defensin-4; OA, oleic acid; qPCR, quantitative PCR.
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suggest that FFAs enhance the skin’s innate antibacterial
defense by inducing the expression of defensin AMP in vivo.
Unlike human skin, murine skin produces a limited amount
of triglycerides and FFAs on the skin surface (Wilkinson and
Karasek, 1966). We therefore used this mouse model to
observe the effects of externally applied FFAs in a system
lacking substantial amounts of endogenous FFAs. We have
developed a tissue chamber model integrated with a dermis-
based, cell-trapped system to mimic the in vivo microenvir-
onment of acne lesions. A tissue chamber bearing human
sebocytes is implanted into ICR mice, and then P. acnes can
be injected into the tissue chamber to induce a host immune
response (Nakatsuji et al., 2008). Thus, we anticipate that the
tissue chamber model will be a useful animal model for
additional studies of the physiological functions of FFAs in
the innate immune defense of human sebocytes.
MATERIALS AND METHODS
Preparation of bacteria
P. acnes (ATCC 6919; American Type Culture Collection, Manassas,
VA) was cultured on Brucella broth agar (BD, Sparks, MD),
supplemented with 5% (v/v) defibrinated sheep blood (LAMPIRE
Biological Laboratories, Pipersville, PA), vitamin K (5 mgml1,
Remel, Lenexa, KS), and hemin (50 mgml1, Remel), under
anaerobic conditions using Gas-Pak (BD) at 37 1C. Single colonies
were inoculated in reinforced Clostridium medium (Oxford, Hamp-
shire, England) and cultured at 37 1C until an OD600 value of B1.0
(logarithmic growth phase) was reached under anaerobic conditions.
The bacteria were harvested by centrifugation at 5,000g for
10minutes, washed with PBS, and suspended with an appropriate
amount of PBS for the experiments.
Quantification of gene expression of AMP in human sebocytes
The immortalized human sebaceous gland cell line SZ95 (Zouboulis
et al., 1999) was cultured on 24-well plates in Sebomed basal
medium (Biochrom, Berlin, Germany) supplemented with 5 ngml1
human recombinant epidermal growth factor (Sigma, St Louis, MO)
and 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Mediatech,
Herndon, VA) at 37 1C under an atmosphere of 5% (v/v) CO2 in air.
LA, PA, and OA (Sigma) were prepared in DMSO and added to the
culture medium at 25 mgml1. Although the concentration of FFA
may be lower than the physiological concentration of total FFAs in
human sebum (approximately 25–45% of total lipids) (James and
Wheatley, 1956; Nordstrom et al., 1986), we chose a dose that does
not influence the viability of SZ95 sebocytes and P. acnes in vitro
(see Supplementary Figures S1 and S2). SZ95 sebocytes (2 106 cells
per well) were incubated with each FFA in 1% FBS-Sebomed for
24 hours at 37 1C. As a negative control, an equal amount of DMSO
(0.5% (w/v)) was added to the culture medium. After incubation,
total RNA was extracted from the cells using TRIzol (Invitrogen,
Carlsbad, CA) and 1 mg RNA was reverse transcribed using iScript
(Bio-Rad, Hercules, CA). Predeveloped TaqMan assay probes
(Applied Biosystems, Foster City, CA) were used for analyzing the
expression of hBD-1 (DEFB1) (gi/28839288), hBD-2 (DEFB4) (gi/
62740068), and hBD-3 (DEFB103B) (gi/151555097). The expression
of human cathelicidin LL-37 (gi/32967658) was evaluated using an
FAM-CAGAGGATTGTGACTTCA-MGB probe with 50-CTTCACCAG
CCCGTCCTTC-30 and 50-CCAGGACGACACAGCAGTCA-30 pri-
mers. For expression of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (gi/20809306), a VIC-CATCCATGACAACTTTGGTA-MGB
probe with primers 50-CTTAGCACCCCTGGCCAAG-30 and 50-TGG
TCATGAGTCCTTCCACG-30 was used. The mRNA expression of
hBD-2 was evaluated by real-time quantitative PCR, normalized to
that of GAPDH, and then expressed relative to that of vehicle-treated
cells.
Fluorescence immunocytochemistry
To detect an FFA-induced increase in the hBD-2 peptide in SZ95
sebocytes, cells were incubated with LA, PA, or OA in 1% FBS-
Sebomed for 24 hours at 37 1C. After incubation, the cells were fixed
by cold acetone and then blocked with PBS containing 3% (w/v) BSA
and 2% (v/v) normal goat serum for 30minutes. After blocking, the
cells were incubated with rabbit anti-hBD-2 IgG (5 mgml1) (Santa
Cruz Biotechnology, Santa Cruz, CA), followed by FITC-labeled anti-
rabbit IgGs (5mgml1) (Santa Cruz Biotechnology). Normal rabbit
IgG (Jackson Immunoresearch Laboratories, West Grove, PA) was
used as a negative control for detection.
To detect CD36 in SZ95 sebocytes, cells were fixed by cold
acetone and then blocked as described above. After blocking, the
cells were incubated with mouse anti-human CD36 monoclonal IgG
(FA6-152) (2mgml1) (Santa Cruz Biotechnology), which is an
antagonist antibody clone against the extracellular domain, followed
by FITC-labeled anti-mouse IgGs (5 mgml1) (Santa Cruz Biotech-
nology). Normal mouse IgG (Jackson Immunoresearch Laboratories)
was used as a negative control for the detection. Nuclei were
counterstained with 40-6-diamidino-2-phenylindole (Sigma). Images
were obtained using an Olympus BX41 fluorescence microscope
(Olympus, Center Valley, PA).
Western blotting for hBD-2
To detect an FFA-induced increase in hBD-2 secretion from SZ95
sebocytes, cells were incubated in a six-well plate with LA, PA, or
OA in 1% FBS-Sebomed for 24 hours at 37 1C. After incubation, the
supernatant of the cell culture medium (2ml) was added to a Sep-
Pak cartridge (Waters, Milford, MA), washed with 10% (v/v)
acetonitrile in 0.1% (v/v) trifluoroacetic acid, and eluted with 60%
(v/v) acetonitrile in 0.1% (v/v) trifluoroacetic acid. The elution was
lyophilized, reconstituted in sample buffer (50 ml) for SDS-PAGE, and
then boiled for 2minutes. The sample (10 ml) was electrophoresed in
a 16% (w/v) polyacrylamide gel (NuSep, Austell, GA) and
electrophoretically transferred onto polyvinylidene difluoride mem-
branes (Millipore, Billerica, MA). The membranes were preincu-
bated for 30minutes in PBS containing 5% (w/v) skim milk and then
incubated with anti-hBD-2 IgG (1 mgml1) at 4 1C overnight. Bound
antibodies were detected with goat anti-rabbit peroxidase-conju-
gated IgG (1:2,000 dilution, Dako, Glostrup, Denmark), and
peroxidase activity was developed using the Western Lighting
Chemiluminescence kit (PerkinElmer, Boston, MA).
In vitro antimicrobial assay for FFA-induced antimicrobial
activity of human sebocytes
To stimulate hBD-2 production in human SZ95 sebocytes, cells
(2 106 per well) were incubated with LA, PA, OA (25 mgml1) or
an equal amount of DMSO (0.5% (v/v)) (vehicle control) in 1%
FBS-Sebomed (250ml) in a 24-well plate for 24 hours. To examine
the antimicrobial activity of each FFA contained in the medium, the
992 Journal of Investigative Dermatology (2010), Volume 130
T Nakatsuji et al.
Antimicrobial Inducibility of FFAs in Sebocytes
FFA-conditioned medium was incubated without sebocytes. After
incubation, the supernatant was centrifuged and filtered with a 0.22-
mm-pore-size filter to remove cell debris. To neutralize the
antimicrobial activity of FFA-induced hBD-2, the supernatant was
preincubated with rabbit anti-hBD-2 IgG (20 mgml1) or normal
rabbit IgG (20 mgml1) (negative control) for 2 hours at 37 1C.
P. acnes (1 106 CFU per ml) was added to the supernatant of the
cell culture and incubated for 5 hours at 37 1C under anaerobic
conditions. FBS-Sebomed (1%) containing each FFA, which was
incubated without sebocytes, was used as a control for this
antimicrobial assay. After incubation, the reaction mixture was
diluted 1:1–1:104 with PBS, and 5 ml of the diluted solution was
spotted on a Brucella broth agar plate for counting CFUs.
In vitro antimicrobial assay for synthetic hBD-2
Synthetic hBD-2 (Peptide Institute, Osaka, Japan), which was
dissolved in 20mM phosphate buffer, pH 6.5, containing 100mM
NaCl, was added to the bacterial suspension. P. acnes (1 106CFU
per ml) was incubated with hBD-2 (0–20 mM) on a 96-well microplate
(100ml per well) in the phosphate buffer at 37 1C for 5 hours. To
examine the synergistic antimicrobial activity of hBD-2 and FFAs,
P. acnes (1 106CFU per ml) was incubated with hBD-2 (0, 2.5, 5,
10 mM) in the phosphate buffer in the presence of LA, PA, or OA
(25 mgml1) on a 96-well microplate (100 ml per well) at 37 1C for
5 hours. The control received only DMSO (0.5% (v/v)) instead of
FFA. After incubation, the CFUs of P. acnes were counted as
described above.
Mechanism of signal transduction for FFA-enhanced hBD-2
expression
To block the function of CD36 on the surface of SZ95 sebocytes,
cells (2 106 per well) cultured on a 24-well plate were
preincubated with mouse anti-CD36 IgG (FA6-152) (5 mgml1),
which is an antagonist antibody clone against the extracellular
domain, or normal mouse IgG in 1% FBS-Sebomed (250 ml) for
2 hours at 37 1C. LA, PA, or OA (25 mgml1) was added to the
preincubated cell culture and incubated for 24 hours at 37 1C. An
equal amount of DMSO (0.5% (v/v)) was used as a control. To block
the NF-kB-mediated signaling pathway in SZ95 sebocytes, the cells
(2 106 per well) cultured on a 24-well plate were preincubated
with BMS-345541 (20 mM), a highly selective inhibitor of IKK (Burke
et al., 2003), or with an equal amount of DMSO (0.1%) in 1%
FBS-Sebomed (250ml) for 1 hour at 37 1C. After preincubation, LA,
PA, or OA (25 mgml1) was added to the cells, which were
subsequently incubated for 24 hours at 37 1C. An equal amount of
DMSO (0.5% (v/v)) was used as a control. After incubation, the
mRNA expression of hBD-2 was determined as described above.
Epicutaneous application of FFA to mouse skin
Eight-week-old female ICR mice (Harlan, Indianapolis, IN) were
used in all animal experiments. The mice were housed according to
institutional guidelines. OA (150 mg in 5% acetone mixed with
15mg of Vaseline (Sigma)) was applied to the surface of the left ear
at 0 and 12 hours. Epicutaneous application of 5% acetone mixed
with 15mg of Vaseline was applied to the right ear as a vehicle
control. To enable observation of mBD-4 immunoreactivity in
sebaceous glands, the ears were embedded in an optimal cutting
temperature compound (Sakura Finetek, Torrance, CA) 12 hours after
epicutaneous application. Frozen sections (6mm) were fixed in a
3.7% (w/v) paraformaldehyde solution in PBS, followed by
permeabilization with 0.1% (w/v) Triton X-100 in PBS, and then
blocked with PBS containing 3% BSA and 2% (v/v) normal goat
serum. The sections were then incubated with affinity-purified rabbit
anti-mBD-4 (2mgml1) (Alpha Diagnostic International, San Anto-
nio, TX), followed by goat anti-rabbit IgG-Alexa 568 conjugate
(5mgml1) (Invitrogen), for 30minutes. Normal rabbit IgG was used
as a negative control for detection. Nuclei were counterstained with
40-6-diamidino-2-phenylindole.
To determine the gene expression of mBD-4, total RNA was
extracted and reverse transcribed as described above. Predeveloped
TaqMan assay probes (Applied Biosystems) were used for analyzing
the expression of mBD-4 (DEFB4) (gi/142379735). For expression of
mouse GAPDH (gi/126012538), a VIC-CATCCATGACAACTTTGG
TA-MGB probe with primers 50-CTTAGCACCCCTGGCCAAG-30 and
50-TGGTCATGAGTCCTTCCACG-30 was used. The mRNA expres-
sion of mBD-4 was evaluated by real-time quantitative PCR,
normalized to that of GAPDH, and then expressed relative to that
of vehicle-treated cells.
Statistical analysis
Data are presented as means±SE. Student’s t-test was used to assess
the significance of independent experiments. The criterion Po0.05
was used to determine statistical significance.
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